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involve 10 patients studied with placebo control. Laberalol
reduced the frequency of angina and increased exercise time and
intensiry, while reducing blood pressure at rest and during
exercise. 16
Gagnon et al. 17 have studied II patients with obstructive
coronary artery disease. Within minutes of intravenous adminis-
trinion oflabetalol arterial pressure fell, accompanied by a reduc-
tion in total peripheral and coronary vascular resistance. A signi-
ficant increase in coronary sinus blood flow occurred as systemic
blood pressure fell. -
We thank Glaxo-Allenbury SA (Pty) Ltd for support and supplies
of labetalol and the placebo.
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Prevention of wound sepsis in
amputations by peri-operative antibiotic
cover with an amoxycillin-clavulanic
acid combination
w. K. J. HUIZINGA,
Summary
J. v. ROBBS, N. A. KRITZINGER
as regards development of sepsis in wounds closed
primarily or left open while under A-CA cover.
In a series of 44 patients with lower limb ischaemia
requiring amputation for major limb sepsis, the per-
formance of a new antibiotic combination with B-
lactamase-inhibiting properties, amoxycillin plus
. c1avulanic acid (A-CA) (Augmentin; Beecham), was
compared with that of penicillin in the prevention of
wound infection. The sepsis rate of ·12,9% in the
group of patie~tsreceiving peri-operative A-CA was
significantly lower than the 76,9% in the penicillin
control group (x2 = 14,48; P<O,OO1).lt is concluded
that there is a need for peri-operative antibiotic
cover in this situation and that A-CA appears to be
highly effective. No statistical difference was found
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Postoperative wound infection after amputation for septic limb
lesions is a source of considerable morbidity.1-3 In the presence
of distal sepsis, the tissue at the amputation site contains.lym-
phatic and vascular channels carrying micro-organisms. Any
surgical procedure undertaken through such tissue is liable to
produce wound infection. This is more likely to occur in poorly
perfused limbs in patients with diabetes than in patients with an
otherwise healthy limb. Cross-infection during operation is
another important factor in the development of stump sepsis·
Prolonged hospital stay and delay in rehabilitation procedures
are factors worth considering, in addition to the inherent mor-
bidity of amputation stump sepsis. The vascular unit at King
Edward VIII Hospital, Durban, is confronted with a large
number of patients presenting with septic complications of lower
limb ischaemia. In many instances reconstructive vascular
surgery is not feasible and an ablative procedure is the only
alternative means of treatment. Because an adequate antimicro-
bial agent is needed in the peri-operative period, a new antibiotic
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Methods
Patients and methods
TABLE I. AGE AND SEX DISTRIBUTION AND INCIDENCE OF
DIABETES
All procedures were done under general or spinal anaesthesia.
The level of ablation was decided beforehand by clinical judge-
ment and limb blood pressure measurements with the Doppler
ultrasound probe, and the feasibility of the elected site deter-
mined intra-operatively by obtaining free muscle bleeding. No
tourniquet was used and the skin was prepared with iodine. Care
was taken to protect the operation site against contamination















were left open in 25 patients and were closed in 6. No drains were
used. The open wounds were covered with a non-medicated
Vaseline gauze.
Bacteriological examination. Two swabs were taken from
the area of sepsis before operation and submitted for anaerobic
and aerobic culture.
Antibiotic administration. In the A-CA group 750 mg of
the antibiotic was administered orally 2 hours before operation
and this dose was repeated 8-hourly for a total of 48 hours. The
patients in the control group received one million units of benzyl
penicillin intravenously with the premedication and thereafter
Control group
In the original isolates Strepc. faecalis (9), Pr. morgani (5), Pr.
mirabilis (6) and Pr. vulgaris (4) were the most frequent aerobes,
and Bace. melaninogenicus (4), Pepc. asaccharolyticus (4), and a
Clostridium sp. (5) the commonest anaerobes. Nine of the 13
patients in this group had clinical evidence of wound sepsis, and
in a total of 10 patients wound swabs were positive for pathogenic
organisms. This represents a sepsis rate of 76,9% (Table IV).
Statistics
The chi-square test with Yates' correction was used for statis-
tical analysis. The sepsis rate in the A-CA group (12,9%) was
found to be much lower than that in the control group (76,9%)
500000 U 6-hourly for 48 hours. The dressing was left undis-
turbed until the 5th postoperative day when the wound was
inspected and assessed on its macroscopic appearance, i.e. the
presence of frank pus, cellulitis or slough. The dressing would be
removed earlier, however, if increasing local pain, fever, soiling
or smell dictated this. Two wound swabs were taken and submit-
ted for microbiological study. The antibiotic was deemed effec-
tive if there was no reappearance of the original pathogenic
organisms at the amputation site. Possible side-effects of the
antibiotic such as rash, diarrhoea or nausea were noted.
Results
A-CA group
A clinically good result was obtained in 28 patients (90,3%),
while in the remaining 3 patients sepsis was visibly present. In I
of these the below-knee amputation was converted to an above-
knee amputation. Another of these patients had a ray amputation
of a toe and the third a transmetatarsal amputation. In both of
these cases a direct field contamination seems likely. The pre-
operative swabs yielded a variety of aerobic and anaerobic orga-
nisms. Most frequently isolated in the aerobic group were Pro-
teus mirabilis and Pr. vulgaris (19), Strepcococcus faecalis (14),
Escherichia coli (8) and Staphylococcus aureus (5), whereas in the
anaerobic group Baceeroides fragilis (12), Bace. melaninogenicus
(10), Closrridium sp. (8) and Pepcococcus magnus (8) were most
common. The postoperative wound swabs were negative in 27
cases, representing a bacteriological success rate of87,1% and a
sepsis rate of 12,9% (Table IV). The 4 failures included the 3
patients previously referred to, and another in whom an A-CA-
sensitive Pr. mirabilis was isolated from the amputation site.
Sepsis occurred in lout of the 6 patients whose wounds were






















TABLE 11. NATURE AND SITE OF LIMB SEPSIS
Wet Ulcer + Gangrene Fore-
gangrene cellulitis + cellulitis Toes foot Leg
15 1 15 6 19 6
7 1 5 8 5- -




combination of amoxycillin and clavulanic acid (A-CA) (Aug-
mentin; Beecham), was studied and its efficacy in preventing
amputation wound sepsis determined. In this combination the
amoxycillin is supplemented by clavulanic acid, which is a B-
lactamase enzyme inhibitor protecting amoxycillin from degra-
dation. This combination has a broad spectrum of activity
against a range of Gram-positive and Gram-negative aerobic
organisms as well as certain anaerobes, including bacteroides and
clostridial species. \Ve would have preferred to compare an
A-CA series with a 'no antibiotic' control series, but because of
the risk of clostridial contamination and gas gangrene we felt
obliged to give penicillin to all the patients in the control series.
The performance of the antibiotic is therefore compared with
that of penicillin as a control.
Control
A total of 44 patients was available for study. They were subdi-
vided into two groups, one group receiving A-CA and the control
group receiving penicillin.
A-CA group. Thirty-three patients were entered into this
trial group but 2 were withdrawn because of sampling errors,
leaving 31 patients for analysis. Most patients were Black males
and the mean age was 55,6 years (range 22-77 years). Diabetes
was present in 13 instances (Table I). Wet gangrene or gangrene
with cellulitis was the usual limb lesion and the commonest site
was the forefoot (Table ll). The lymph nodes in the groin
appeared clinically involved in 24 cases. Below-knee amputation
was performed in 15 patients, above-knee amputation in 13 and
other procedures in 3 (Table Ill).
Control group. In this group of 13 patients, 12 were male
and 4 had diabetes. The· mean age was 53,4 years (range 38-79
years) (Table I). Wet gangrene was present in 7, gangrene and
cellulitis in 5, and ulceration and cellulitis in I patient. The site of
sepsis was the forefoot in 8 patients and the foot and leg in 5
(Table ll). Below-knee amputation was performed in 8 instances
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TABLE IV. INCIDENCE OF WOUND SEPSIS
Bacteriological examination
Negative Positive
No. % No. %
27 87,1 4 12,9
Clinical signs
Absent Present
Group Total No. % No. %
A-CA 31 28 90,3 3 9,7
Con-
trol 13 4 30.7 9 69,3 3 23,1 10 76,9
x" = 14,48
P< 0.001
and this difference was shown to be highly significant (x 2 = 14,48;
P < 0,001). No statistical difference was found as regards
the occurrence of infection in the wounds which were closed
primarily and those left open while under peri-operative A-CA
cover (x2 = 0,14).
Discussion
Several factors contribute to delay in wound healing after ampu-
tation. Malnutrition, ischaemia, haematoma formation and sep-
sis all play an important role. Amputation-related mortality
ranges from 2% to 37%.1-3. 5. 6 This is undoubtedly due to the poor
risk many of these patients present because of age and general-
ized vasculopathy. Husron el af.2 quote a 15% mortality among
100 patients who underwent above-knee amputation, of which
54% was sepsis-related. Robinson 5 reported a 7% mortality for
below-knee, 17% for through-knee and 30% for above-knee
amputations. Potts el al. 6 mentioned II infections in below-knee
and 11 in above-knee amputations out of 83 operations in
patients with diabetes and peripheral vascular disease. Sepsis
accounted for 3 deaths of the total of 10. No mention was inade of
peri-operative antibiotics, but in a large series of283 amputati-
ons l these were not routinely used and sepsis was the cause of
death in 9 patients.
Most of the deaths must be ascribed to cardiovascular and
pulmonary complications, and these symptoms should be care-
fully monitored in the immediate pre- and postoperative period.
Wound infection might be caused by operating through tissues
with blood and lymphatic vessels carrying bacteria, cross-
infection occurring in the operating theatre (either from the
patient or another source), or secondary infection occurring
postoperatively.4 Many organisms originate from the patient's
own gastro-intestinal tract, and attempts have been made to
lower the amputation wound sepsis rate by reducing the intesti-
nal flora. 7 In our group of 44 patients we encountered a Closlri-
dium species which occurred pre-operatively (from the devital-
ized limb) in 13 instances, and from the amputation wounds in
2.8 In his review of85 clostridial wound infections, Parker8 found
47 in lower limb amputations for ischaemia and 13 of these in
diabetics. He therefore advocated penicillin prophylaxis and
non-suturing of muscles.
In order to reduce the postoperative incidence of these infec-
tions, attention should be paid to meticulous skin preparation
and draping before operation. Amputation at an ischaemic site
certainly predisposes to sepsis, and the choice of the amputation
site is an important one. The aim is to preserve as much length of
limb as possible without compromising its viability. Below-knee
amputation is preferable to the above-knee procedure because of
a lower associated mortality rate, preservation of the knee joint
with better prospects of rehabilitation to ambulation, less stump
pain and fewer demands on the energy reserves of the patient.
We use the Doppler ultrasound probe to measure peripheral
arterial pressure and the pressure index (below-knee pres-
sure/brachial systolic pressure). Ankle pressure measurements
correlate well with the calf blood flow, and the pressure index
reflects the degree of arterial disease in the leg. Healing after a
below-knee amputation can be predicted with pressure readings
>70 mmHg and a pressure index >0,3,9-11 although patients
with marked vessel calcification might have pressure indices
> I.l2 Other techniques measure skin blood flow (isotope clear-
ance, thermography, photopletysmography), as skin circulation
correlates better with wound healing than does muscle blood
flow. 13.14
Clinical judgement depends on appearance at operation and
the amount of free bleeding obtained. However, successful heal-
ing has taken place when little bleeding has occurred 9 Wound
infection has also been associated with the use of drains, notably
the corrugated Penrose or sump drains. Berardi and Keonin l5
had a 27,6% incidence of stump sepsis in a series of 163 amputa-
tions, the majority in stumps that were drained (82,5% v. 17,5%
for non-drained stumps). We do not use drains, but it has been
our practice not to close amputation wounds in the presence of
distal sepsis. As this has the disadvantage of requiring a second
procedure, a direct primary closure was performed in a group of
6 patients receiving A-CA. One of them developed a wound
infection compared with 3 patients of the 25 whose wounds were
left open. Although these numbers are small, it appears that
antibiotic cover might obviate the need for delayed primary
closure; this is promising. Few studies have been published on
the need for and choice of prophylactic antibiotics. Parker8 and
Jamieson and Hill l2 advise the routine use of penicillin against
clostridial infection, although this is ineffective against most
Gram-negative organisms. Hares el al.7 used pre-operative oral
metronidazole and neomycin. In our series we have shown the
need for an effective antibiotic with a broad spectrum of activity
against organisms commonly found in septic ischaemic lower
limb lesions. From our results we conclude that the combination
of amoxycillin and the R-Iactamase inhibitor, clavulanic acid, is a
highly effective formulation, and its use as a peri-operative anti-
biotic for amputations is recommended.
We should like to [hank Messrs Beecham Pharmaceuticals Ltd for
supporting this study.
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